Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination After Surgery for Pet Dogs With High-Grade Glioma

Cancers - Switzerland
doi 10.3390/cancers11020137
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Annexin A5 as an Immune Checkpoint Inhibitor and Tumor-Homing Molecule for Cancer Treatment

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

High Mortality and Poor Treatment Efficacy of Immune Checkpoint Inhibitors in Patients With Severe Grade Checkpoint Inhibitor Pneumonitis in Non‐small Cell Lung Cancer

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

International Differences in Treatment and Clinical Outcomes for High Grade Glioma

PLoS ONE
Multidisciplinary
2015English

Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-Checkpoint Inhibitor Treatment for Malignant Melanoma

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2018English

Immune Suppression During Oncolytic Virotherapy for High-Grade Glioma; Yes or No?

Journal of Cancer
Oncology
2015English

Evaluation of Antithyroglobulin Antibodies After Routine Vaccination in Pet and Research Dogs

Journal of the American Veterinary Medical Association
Veterinary
2002English

Treatment Outcome of High-Grade Spinal Cord Glioma

Spinal Surgery
2013English

Timing of Surgery and Bevacizumab Therapy in Neurosurgical Patients With Recurrent High Grade Glioma

Journal of Clinical Neuroscience
MedicineSurgeryNeurologyPhysiology
2015English

Circulating Biomarkers for High-Grade Glioma

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy